2015 Feb 2. pii: S0031-9384(15)00066-9. doi: 10.1016/j.physbeh.2015.01.038. [Epub ahead of print]
Abstract
This study evaluated the influence of the pre-treatment with AM251 (a cannabinoid type I receptor (CB1) selective antagonist) on the stress-induced antinociception promoted by restraint in the fish Leporinus macrocephalus. The application of 3 and 5min of restraint stress promoted an inhibition of the behavioural response to the subcutaneous injection of 3% formaldehyde (increase in locomotor activity), suggesting the activation of an antinociceptive system. The acute intraperitoneal administration of AM251 (3mg.kg ¯ 1) impaired this antinociceptive response induced by 3 and 5min of restraint stress. The fish treated with AM251 before the application of restraint stress presented an increase in locomotor activity after the subcutaneous injection of formaldehyde, similar to fish not exposed to restraint, suggesting that the stress-induced antinociception promoted by restraint in fish is probably mediated by cannabinoid CB1 receptors. The results presented in this paper suggest the participation of the endocannabinoid system in nociception modulation in fish, supporting the hypothesis that an endogenous antinociceptive system activated by restraint stress is present in fish and that the modulation of antinociception by the CB1 receptor is evolutionary well-conserved across vertebrates.
Copyright © 2015. Published by Elsevier Inc.
Copyright © 2015. Published by Elsevier Inc.
KEYWORDS:
endocannabinoid system; formaldehyde test; nociception; pain; stress; welfare
- PMID:
- 25656689
- [PubMed – as supplied by publisher]